🏛️ Verified NIH Record • Updated 2025-11-27

Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients (NCT04289142)

Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients: CODEX Trial

🟢 Recruiting Phase4 💊 Investigational Drug / Biologic Sponsor: Sunnybrook Health Sciences Centre

🩺 Plain-English Summary (8th-Grade Level)

Anesthesia is a drug induced, reversible, comatose state that facilitates surgery and it is widely assumed that cognition returns to baseline after anesthetics have been eliminated. However, many patients have persistent memory impairment for weeks to months after surgery. Cardiac surgery appears to carry the highest risk of postoperative cognitive dysfunction (POCD). These cognitive deficits are associated with increased mortality, prolonged hospital stay and loss of independence. The investigators propose to investigate the role of Dexmedetomidine (DEX) in preventing long-term POCD after cardiac surgery and enhancing early postoperative recovery. It is anticipated that DEX will be the first effective preventative therapy for POCD, improve patient outcomes, and reduce length of stay and healthcare costs.

Who can join: Review the eligibility criteria below.

Location: Royal Columbian Hospital — Vancouver, British Columbia

Age range: 60 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (8 Sites)

  • Royal Columbian Hospital — Vancouver, British Columbia
  • St. Paul's Hospital — Vancouver, British Columbia
  • London Health Sciences — London, Ontario
  • Sunnybrook Health Sciences Centre — Toronto, Ontario
  • St. Michael's Hospital — Toronto, Ontario
  • Toronto General Hospital — Toronto, Ontario
  • Laval University — Québec, Quebec
  • University of Saskatchewan — Saskatoon, Saskatchewan

📞 Contact the Study Coordinator

Phone: (416) 480-6100

Email: stephen.choi@sunnybrook.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Delirium clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗